- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 40/32 - Récepteurs des lymphocytes T [TCR]
Détention brevets de la classe A61K 40/32
Brevets de cette classe: 641
Historique des publications depuis 10 ans
|
13
|
12
|
10
|
38
|
47
|
72
|
36
|
14
|
174
|
147
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20720 |
23 |
| Fred Hutchinson Cancer Center | 474 |
19 |
| Board of Regents, The University of Texas System | 6102 |
17 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
16 |
| Memorial Sloan-Kettering Cancer Center | 2038 |
14 |
| Medigene Immunotherapies GmbH | 72 |
12 |
| University Health Network | 1061 |
11 |
| The Trustees of the University of Pennsylvania | 4414 |
10 |
| A2 Biotherapeutics, Inc. | 96 |
9 |
| Kite Pharma, Inc. | 451 |
8 |
| Kyoto University | 2898 |
8 |
| Adaptimmune Limited | 158 |
7 |
| Sloan-Kettering Institute for Cancer Research | 609 |
7 |
| Memorial Hospital for Cancer and Allied Diseases | 398 |
7 |
| BioNTech US Inc. | 90 |
7 |
| Institut Curie | 615 |
6 |
| The United States of America,as represented by the Secretary, Department of Health and Human Service | 124 |
6 |
| TScan Therapeutics, Inc. | 60 |
6 |
| BioNTech SE | 791 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
5 |
| Autres propriétaires | 437 |